Investing First patient dosed in Phase IIb imaging for Brain Mets by April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post S&P 500 Rises from Bearish to Neutral, But Will It Last? You may also like Tech Weekly: Tech Stocks Feel the Heat Amid... November 8, 2025 Top 5 Canadian Mining Stocks This Week: Quarterback... November 8, 2025 Lobo Tiggre: Copper is My Highest-Confidence 2026 Trade,... November 8, 2025 Rich Checkan: Silver to Outpace Gold in 2026,... November 8, 2025 Surface Metals Inc. Grants Options and Provides Update... November 8, 2025 $2million placement to advance Argentine exploration November 7, 2025 Nevada Sunrise Closes $650,000 Private Placement November 7, 2025 Crypto Market Update: Ripple Raises US$500 Million, Canada... November 7, 2025 Agriculture Market Update: Q3 2025 in Review November 7, 2025 Altech – Service Data Confirms Exceptional Failure Rate November 6, 2025